Defunct Company
Total Trials
6
As Lead Sponsor
4
As Collaborator
2
Total Enrollment
441
NCT00787007
Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers
Phase: Phase 1
Role: Lead Sponsor
Start: Sep 30, 2008
Completion: Dec 31, 2008
NCT00998920
Multi-Dose Safety and Pharmacokinetic Study of S-Equol in Healthy Volunteers
Start: Dec 31, 2008
Completion: Apr 30, 2009
NCT00962390
Efficacy and Safety of S-Equol on Men With Benign Prostatic Hyperplasia
Phase: Phase 2
Start: Jun 30, 2009
Completion: Jan 31, 2016
NCT00962585
Efficacy and Safety of S-equol on Vasomotor Symptoms in Menopausal Patients
Start: Jun 30, 2010
Completion: Nov 30, 2011
NCT02142777
S-Equol in Alzheimer's Disease (SEAD) Trial
Role: Collaborator
Start: Jul 31, 2014
Completion: Apr 30, 2016
NCT03101085
S-Equol in Alzheimer's Disease 2 Trial
Phase: Phase 1/2
Start: May 5, 2017
Completion: Mar 1, 2021